
All of us at $LCTX and CCN wish to express our gratitude to those who inspire us as #WeWorktoRestore - function, dignity, strength, clarity, independence, and hope. @CEO_Culley #CellTherapy #ReplaceAndRestore #Careers

A clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

All of us at $LCTX and CCN wish to express our gratitude to those who inspire us as #WeWorktoRestore - function, dignity, strength, clarity, independence, and hope. @CEO_Culley #CellTherapy #ReplaceAndRestore #Careers

$LCTX reported third quarter 2026 financial results and will host a conference call at 4:30 pm ET / 1:30 pm PT today to provide a business update. Learn more: investor.lineagecell.com/new… @CEO_Culley | #ReplaceAndRestore

$LCTX announces the acquisition of NeuroAirmid Therapeutics, Inc. along with certain worldwide rights to HUNT1 (hNSC01), a pluripotent stem cell derived clinical-stage neural cell therapy program for the treatment of Huntington's Disease. This acquisition adds a third clinical stage asset to Lineage's development pipeline, and aligns with the company's capabilities in cell manufacturing, process development, and scale-up. The HUNT1 program represents the culmination of decades of research led by Leslie Thompson, Ph.D., and is currently being evaluated in the #REGEN4HD clinical study at @UCIrvineHealth. For more details, see here: investor.lineagecell.com/new… #CellTherapy #HuntingtonDisease #RegenerativeMedicine #UniversityofCaliforniaIrvine @CEO_Culley @CIRMNews @HDSA @HuntingtonSG @hdfcures

$LCTX announced it will report Q3 2026 financial and operating results on Thursday, November 12, 2026. Management will host a conference call at 4:30 p.m. ET/ 1:30 p.m. PT to provide a business update. For more: investor.lineagecell.com/new… #ReplaceAndRestore

We appreciate @AlexZank from @CFOBrew featuring $LCTX’s CFO Jill Howe, to discuss our approach to advancing promising cell therapy opportunities. Jill shares how we use our AlloSCOPE™ platform to identify therapeutic programs with strong market potential and how we strategically allocate capital to move them forward. For the full article, see here: cfobrew.com/stories/finding-… #CellTherapy #Biotech #RegenerativeMedicine #CFO #LifeSciences

$LCTX’s @CEO_Culley is looking forward to joining Ben Beneski, SVP & CTO of @AllogeneTx, on the next live @_CellandGenewebinar, moderated by @Erin_Harris1 to discuss the requirements for #celltherapy late-stage development and commercialization. Register to watch on 11/12 here: event.on24.com/wcc/r/5524667… #CellTherapy #GeneTherapy #RegenerativeMedicine #ReplaceandRestore

$LCTX #Type1Diabetes #CellTherapy #Research
It was amazing to meet last week with the world renowned “father” of islet cell transplants @CamilloRicordi of @DRIFoundation_ & @umiamimedicine to discuss ILT1, our islet cell transplant program. His work led to $ELED and he literally invented the donor islet isolation device. An incredible career with so many new possibilities ahead. $LCTX

$LCTX today provided an update on its ReSonanceTM (ANP1) program for #hearingloss. The program is built on our patented AlloSCOPETMmanufacturing platform, and is currently being developed under a research collaboration with William Demant Invest A/S (WDI). Learn more: investor.lineagecell.com/new… @CEO_Culley | #ReplaceAndRestore #CellTherapy #HearingLoss #RegenerativeMedicine @ca_navntoft

#CTS2026 replays are now available on demand. $LCTX’s @CEO_Culley was proud to sit alongside presenters from @AbbVie, Oculis, @Valitorbio, @NeurotechPharma, @RecenseM and others, as part of the “From Innovation to Approval: Bringing Novel Treatments to Market” panel, moderated by Pravin U. Dugel, M.D., of @OCUTX. Watch the recorded sessions: ctsretina.org/ #CTSRetina #ClinicalTrials #Ophthalmology #CellTherapy #ReplaceandRestore | @CEO_Culley @ArshadKhanani @CTS_Tahoe

Nice to see our partner highlighting RPE cell therapy. At #AAO2026, #retina specialists heard firsthand about treatments that can make a meaningful difference for #dryAMD patients. $LCTX #OpRegen #ReplaceandRestore @CEO_Culley

$LCTX wishes to thank everyone who participated in the Spinal Cord Injury Patient-Focused Drug Development Meeting, especially individuals living with #SCI and care partners who shared their experiences and perspectives. Several themes came through clearly, including how restoring any kind of function, even incremental improvements, can translate into meaningful changes in everyday activities, personal care and quality of life. @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

$LCTX congratulates @ca_navntoft and the Eriksholm Research Center for their review of the current status of cell therapy for restoring auditory nerve function, which highlights the importance of combining #celltherapy with surgical approaches to help people with hearing loss. We look forward to continued progress on our ReSonance® (ANP1) program, an auditory neuronal cell transplant program to treat hearing loss. Read the full article: sciencedirect.com/science/ar… #ReplaceAndRestore #HearingLoss | @CEO_Culley

Join us on September 29 for the @scipfdd Spinal Cord Injury Patient-Focused Drug Development Meeting — a free, virtual event where the SCI community will share their experiences and needs directly with the FDA. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Register now for the free, virtual @scipfdd SCI PFDD Meeting on Sept. 29! Participants will discuss daily life with SCI, experiences with treatments, and priorities for future research. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Lineage is proud to support the upcoming @scipfdd SCI Patient-Focused Drug Development (PFDD) Meeting on September 29! This free, virtual event brings the experiences of individuals with SCI directly to FDA and treatment developers. scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Today, $LCTX announced the issuance of a U.S. Patent covering the company’s proprietary AlloSCOPE™ 5D manufacturing platform. investor.lineagecell.com/new… #CellManufacturing #ReplaceAndRestore